SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Heart Attacks, Cancer and strokes. Preventative approaches
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: russet4/3/2024 7:22:02 PM
1 Recommendation

Recommended By
JSB

   of 39318
 
100 Percent Cancer Remission of Patients in Monoclonal Antibody Trial | Facts Matter


theepochtimes.com

Facts Matter


Views 52.5K •
Apr-02-2024

According to the results of a recent study, researchers have found a treatment that completely removed the rectal cancer in every patient that participated. Meaning that every single patient in the study is in remission—and with no chemotherapy, no radiation, and no surgery.

Even though the study was small, the results are not only heartening, but also, according to the lead researcher, they open up a potential new corridor at fighting cancer, which they will be expanding quickly to stomach, pancreatic, and bladder cancer.

Furthermore, the therapy that they’re testing (monoclonal antibodies) has none of the toxic side-effects of the other treatments for cancer that are currently used at scale.

And so, with all these positive elements lining up, let’s go through this study together.

Episode Resources:

?? Full Study:

ept.ms

??No Farmers No Food DVD:

epochtv.shop
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News